These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22770787)

  • 1. Types of combined oral contraceptives used by US women.
    Hall KS; Trussell J
    Contraception; 2012 Dec; 86(6):659-65. PubMed ID: 22770787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Types of combined oral contraceptives used by US women.
    Creinin MD
    Contraception; 2013 Jul; 88(1):192-3. PubMed ID: 23410715
    [No Abstract]   [Full Text] [Related]  

  • 3. User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives.
    Liang SY; Grossman D; Phillips KA
    Contraception; 2012 Dec; 86(6):666-72. PubMed ID: 22770791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin-only contraceptive pill use among women in the United States.
    Hall KS; Trussell J; Schwarz EB
    Contraception; 2012 Dec; 86(6):653-8. PubMed ID: 22682722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to letter to the editor.
    Hall KS; Trussell J
    Contraception; 2013 Jul; 88(1):193. PubMed ID: 23375355
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A crossover pill study among Sudanese women.
    Gerais AS; Rushwan H
    Int J Gynaecol Obstet; 1985 Jun; 23(3):229-33. PubMed ID: 2865187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.
    Tepper NK; Phillips SJ; Kapp N; Gaffield ME; Curtis KM
    Contraception; 2016 Sep; 94(3):262-74. PubMed ID: 26002804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
    Elomaa K; Lähteenmäki P
    Contraception; 1999 Nov; 60(5):275-9. PubMed ID: 10717779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
    Kay CR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):762-5. PubMed ID: 6801981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiphasic oral contraceptives. Efficacy and metabolic impact.
    Ellis JW
    J Reprod Med; 1987 Jan; 32(1):28-36. PubMed ID: 3550064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choosing the Right Oral Contraceptive Pill for Teens.
    Powell A
    Pediatr Clin North Am; 2017 Apr; 64(2):343-358. PubMed ID: 28292450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate.
    Corson SL
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1556-61. PubMed ID: 8178906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose oral contraceptives: health consequences of discontinuation.
    Ansbacher R
    Contraception; 2000 Dec; 62(6):285-8. PubMed ID: 11239614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.